Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis

19 Dec 2020

Abstract excerpt

Asherman’s Syndrome (AS) is an uncommon, acquired, and refractory gynecological disorder. Current treatment was still limited, and stem cell-based therapy has been proposed as a novel strategy for management of AS. Here, we conducted a meta-analysis of self-controlled clinical trials to assess the effectiveness and safety of stem cell-based therapy in Asherman syndrome patients who have failed in conventional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gynecological conditions and treatments
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33414830
DOI: 10.1155/2020/8820538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-AnalysisPMID 33414830Read ↗

Autologous cell therapy with CD133+ bone marrow-derived stem cells for Asherman Syndrome: a phase 1/2 trialSemantic proximity Read ↗

Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell TherapiesSemantic proximity Read ↗

Effects of uterus derived mesenchymal stem cells and their exosomes on asherman’s syndromeSemantic proximity Read ↗

Strategies for managing Asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approachSemantic proximity Read ↗

Asherman syndrome--one century later.Semantic proximity Read ↗

Decoding the endometrial niche of Asherman’s Syndrome at single-cell resolutionSemantic proximity Read ↗

Decoding the endometrial niche of Asherman’s Syndrome at single-cell resolutionSemantic proximity Read ↗

Levonorgestre-lintrauterine system(LNG-IUS) plus Metformin compared with Megestrol Acetate (MA)plus Metformin as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well differentiated endometrial cancer:a single-center retrospective studySemantic proximity Read ↗

Asherman's Syndrome: it may not be all our fault.Semantic proximity Read ↗

Stem Cell Therapies for Human Infertility: Advantages and ChallengesSemantic proximity Read ↗

Endometrial stem cells in regenerative medicineSemantic proximity Read ↗

Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.